<DOC>
	<DOCNO>NCT02024945</DOCNO>
	<brief_summary>The purpose study assess Quality Life ( QoL ) urination urge , incontinence , micturition frequency include nocturia 4 12 week treatment propiverine .</brief_summary>
	<brief_title>Efficacy , Tolerability Impact Quality Life Propiverine Patients With Overactive Bladder Syndrome</brief_title>
	<detailed_description>The drug test study call propiverine . Propiverine test evaluate Quality Life ( QoL ) improvement OAB symptoms people take propiverine . The study enroll approximately 1000 patient treat physician decide treat propiverine 15mg tablet 30 mg regulate release capsule part normal clinical practice . All participant ask keep voiding diary 2 consecutive day complete QoL questionnaire 1st visit subsequent visit . This multi-centre trial conduct Belgium . The overall time participate study 12 week . Participants make 3 visit healthcare provider .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Propiverine</mesh_term>
	<criteria>1 . Written informed consent . 2 . At least 18 year age . 3 . Patients complaint Overactive Bladder Syndrome ( OAB ) without urge incontinence , OAB urge incontinence , mixed urinary incontinence . 4 . Patients consult GP urologist first time complaint stop OAB treatment since least one month . 5 . Receiving propiverine prescription accord Summary Product Characteristics ( SPC ) . None , per SPC contraindication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Drug therapy</keyword>
</DOC>